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Abstract
Background Esophageal intraluminal baseline impedance
reflects the conductivity of the esophageal mucosa and may
be an instrument for in vivo evaluation of mucosal integrity
in children with gastroesophageal reflux disease (GERD).
Laparoscopic antireflux surgery (LARS) is a well-estab-
lished treatment option for children with proton pump
inhibitory (PPI) therapy resistant GERD. The effect of
LARS in children on baseline impedance has not been
studied in detail. The aim of this study was to evaluate the
effect of LARS on baseline impedance in children with
GERD.
Methods This is a prospective, multicenter, nationwide
cohort study (Dutch national trial registry: NTR2934)
including 25 patients [12 males, median age 6 (range 2–18)
years] with PPI-resistant GERD scheduled to undergo
LARS. Twenty-four hour multichannel intraluminal
impedance pH monitoring (MII-pH monitoring) was per-
formed before and 3 months after LARS. Baseline impe-
dance was evaluated during consecutive 2-h intervals in the
24-h tracings.
Results LARS reduced acid exposure time from 8.5 %
(6.0–16.2 %) to 0.8 % (0.2–2.8 %), p\ 0.001. Distal
baseline impedance increased after LARS from 2445 X
(1147–3277 X) to 3792 X (3087–4700 X), p\ 0.001.
Preoperative baseline impedance strongly correlated with
acid exposure time (r -0.76, p\ 0.001); however, no
association between symptomatic outcome and baseline
impedance was identified.
Conclusions LARS significantly increased baseline impe-
dance likely reflecting recovery of mucosal integrity. As
the change in baseline impedance was not associated with
the clinical outcome of LARS, other factors besides
mucosal integrity may contribute to symptom perception in
children with GERD.
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and Other Interventional Techniques 
Multichannel intraluminal impedance (MII) combined with
pH monitoring is a well-established technique for the
assessment of gastroesophageal reflux disease (GERD) in
both children and adults [1–4]. Changes in conductivity
between multiple electrode pairs on a single-sensor MII-
catheter allow detection of intra-esophageal movement of
saliva during swallowing and the occurrence of gastroe-
sophageal reflux (GER). In the absence of GER or swal-
lowing, the esophagus is collapsed and the esophageal wall
comes directly in contact with the MII-pH sensor catheter
[5]. The impedance value during these periods, commonly
referred to as baseline impedance, reflects the intrinsic
electrical conductivity of the esophageal wall and may
offer an in vivo tool to assess the integrity of the esopha-
geal mucosa [6]. Baseline impedance values in healthy
volunteers are usually high, whereas GERD patients
express low baseline impedance values. Low baseline
impedance values have been associated with Barrett’s
esophagus or severe esophagitis [7], but recently they were
also linked to acid-induced mucosal changes in patients
with non-erosive reflux disease [6, 8, 9].
Furthermore, comparison with the golden standard, the
Ussing Chamber technique showed that baseline impe-
dance was closely correlated to TEER and fluorescein
permeability as measured with the Ussing chamber [10].
Recovery of impaired mucosal integrity, reflected by
increased baseline impedance, may relieve symptoms in
GERD patients and be a marker for the clinical outcome of
therapy [6, 11]. Previous studies evaluating the effect of
proton pump inhibitors (PPIs) on baseline impedance in
children and adults with GERD showed an increase in
baseline impedance during acid suppressive therapy
[11–13]. However, these studies did not reveal a correla-
tion between the recovery of baseline impedance and
symptomatic outcome [12, 13].
Laparoscopic antireflux surgery (LARS) to treat severe,
PPI-therapy resistant GERD aims to reduce reflux episodes
and symptoms [14]. At present, the effect of LARS on
esophageal mucosal integrity has not previously been
studied in detail. The aim of this study is to assess the
effect of LARS on baseline impedance and to explore if
changes in baseline impedance are associated with the
clinical outcome of LARS.
Methods
Study design
We performed a prospective multicenter study in three
University Medical Centers in the Netherlands that are
specialized in performing fundoplication in children
[Wilhelmina children’s Hospital, University Medical
Center Utrecht (UMCU); Sophia’s Children’s Hospital,
Erasmus University Medical Center (Erasmus MC) and
Maastricht University Medical Center (MUMC)]. From
July 2011 until December 2013, we prospectively included
pediatric patients diagnosed with PPI-therapy resistant
GERD. All patients had been treated with high dosages of
PPI for at least 6 months, and GERD was defined as: (1)
troublesome GERD symptoms, (2) pathological reflux on
24-h pH monitoring and (3) a positive SAP (symptom
association probability) assessment (C95 %).
Patients who underwent previous esophageal or gastric
surgery (except previous gastrostomy placement) and those
with structural abnormalities other than esophageal hiatal
hernia were excluded. Patients were studied before and
3 months after the surgical procedure.
Surgical procedure
All laparoscopic fundoplicationprocedureswereperformedby
pediatric surgeons experienced in minimal invasive pediatric
surgery. In the UMCU, the anterior, partial fundoplication
according to Thal [15] was used to perform fundoplication.
The other two centers (Erasmus MC and MUMC) used the
posterior, total fundoplication according toNissen [16].Before
fundoplication, the distal esophagus was fully mobilized, and
the distal 3 cmof the esophaguswas repositionedback into the
abdomen. Both vagal nerves were identified, and a crusplasty
was performed routinely (UMCU and EMC). Thereafter, the
fundoplication was constructed. The Thal fundoplication was
performed by plicating the fundus of the stomach over 270
against the distal anterior intra-abdominal part of the esopha-
gus and the diaphragmatic crus [17]. A floppy Nissen was
constructed with one of the sutures of the 360 posterior wrap
incorporated in the esophageal wall [16].
Ambulatory 24-h multichannel intraluminal
impedance pH monitoring
Ambulatory 24-h MII-pH testing was conducted after at
least 3-day cessation of all medications that affect gas-
trointestinal motility and/or acid secretion. Measurements
were performed using a combined pH-impedance catheter
assembly that consisted of six impedance segments and one
ISFET pH electrode (Unisensor AG, Attikon, Switzerland).
The pH electrode was positioned 5 cm above the upper
border of the manometrically localized lower esophageal
sphincter (LES). Impedance and pH signals were stored on
a digital data logger (Ohmega, Medical Measurement
Systems, Enschede, The Netherlands), using a sampling
frequency of 50 Hz. Patients and/or their parents were
instructed to continue their regular diet, to report GERD
symptoms and to keep a diary of their consumptions and
body position (supine or upright) during the measurement.
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Reflux-specific questionnaires
To assess reflux symptoms, patients and/or their parentswere
asked to fill out the validated age-adjusted Gastroesophageal
Reflux Symptom Questionnaire (GSQ) before and 3 months
after LARS [18]. Reflux symptoms and dysphagia were
scored for frequency and severity on a score ranging from 1
(none) to 7 (most severe). Symptoms were defined as: no
symptoms (no symptoms reported); mild (mild symptoms,
weekly); moderate (mild symptoms, daily or severe symp-
toms, weekly) and severe (severe symptoms, daily). Reflux
symptoms were scored using the symptoms heartburn,
regurgitation, food refusal and vomiting.
Data analysis
Baseline impedance values were calculated for two specific
segments in the esophagus during consecutive 2-h intervals
in the 24-MII-pH tracings as previously described [11].
Periods of C30 s not containing any swallows or gastroe-
sophageal reflux episodes were selected, and the averaged
impedance value over this specific time period at two of the
in total six impedance segments (Z6-distal and Z2-proxi-
mal) was calculated, using a specific function incorporated
in the analysis software (Ohmega, MMS, Enschede, The
Netherlands). The 2-hourly obtained baseline impedance
values for each segment were averaged and used for further
analysis. The 24-h MII-pH tracings were further analyzed
for acid exposure time, the number and acidity of reflux
episodes according to previously described definitions [19].
Acid exposure time was defined as pathological when pH
\4 during[6.0 % of time during 24-h monitoring [20, 21].
Reflux episodes reaching the proximal (z2) impedance
segment were classified as proximal. Baseline impedance
throughout the manuscript refers to baseline impedance in
the distal (z6) segment, unless stated otherwise.
Ethical approval and trial registration
This study was registered with the Dutch national trial
registry (www.trialregister.nl; Identifier: 2934). Ethical
approval for this prospective multicenter study was
obtained from the University Medical Center Utrecht
Ethics Committee, and local approval was obtained by the
two participating centers (Erasmus MC and MUMC). Prior
to initiating any trial-related study procedure, informed
consent from the patients’ parents was obtained.
Statistical analysis
Continuous parametric variables were expressed as
mean ± standard error of the mean (SEM). Nonparametric
variables were expressed as median, with interquartile
ranges (IQR). For continuous parametric outcomes, a
paired sample T test was performed. Nonparametric con-
tinuous outcomes were analyzed using the Wilcoxon
signed-rank test. Correlations between different parameters
were calculated using the Pearson correlation coefficient or
Spearman’s rank correlation coefficient as appropriate.
Linear regression analysis was performed to identify pos-
sible determinants of the effect of LARS on baseline
impedance. Determinants of interest included: age, type of
fundoplication and changes in acid exposure time. A
p value below 0.05 was considered statistically significant.
All statistical analyses were performed using commercially
available computer software (IBM SPSS Statistics for
Windows, Version 22. Armonk, NY: IBM Corp.).
Results
In total, 25 children were included in our study. Mean age of
the included patients was 6 (range 2–18) years at the time of
fundoplication. Five children (80 %) had normal neurode-
velopment (NN), while impaired neurodevelopment (NI)
was seen in five children (20 %). Patient demographics are
shown in Table 1. Thal fundoplication was performed in 18
and Nissen fundoplication in seven children. In all patients,
fundoplication could be completed by laparoscopy.
The caregivers of all 25 patients filled out both pre- and
postoperative reflux symptom questionnaires. Pre-operative
24-h pH-MII tracings were completed in all 25 patients.
After surgery, 24-h pH-MII could not be performed in two
patients due to refusal of the tracing by the caregivers.
Postoperative tracings were successfully completed in 23
of the 25 children. Preoperative esophagogastroduo-
denoscopy was performed in 18 patients. In 13 of these
patients, macroscopic and/or microscopic acid-induced
changes in the esophagus were observed.
Baseline impedance before antireflux surgery
Median baseline impedance before surgery was 2245 X,
with a range from 430 to 4401 X. Spearman’s rho corre-
lation coefficient showed a strong negative correlation
Table 1 Baseline characteristics
(Median; IQR)
Age at time of operation (years) 6.0 (3.0–11.0)
Duration of hospital admission (days) 3.0 (2.0–4.5)
n (%)
Male gender 12 (48.0 %)
Impaired neurodevelopment 5 (20.0 %)
Gastrostomy preoperatively in situ 4 (16.0 %)
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between distal baseline impedance and acid exposure time
(r -0.76, p\ 0.001) before surgery (Fig. 1A). Baseline
impedance also negatively correlated with other reflux
parameters, such as reflux episodes lasting longer than
5 min (r -0.55, p = 0.005) and number of acid reflux
episodes (r -0.55, p = 0.005). The number of non-acid
reflux episodes showed no correlation with baseline
impedance (r -0.03, NS).
In patients who underwent preoperative endoscopy, a
trend toward significance was observed when comparing
baseline impedance in patients with macroscopic and/or
microscopic signs of esophagitis (n = 13) to those with no
sign of inflammation (n = 5) [resp. 1788 (IQR
677–3187 X) versus 2928 X (IQR 2591–4364 X),
p = 0.09]. Baseline impedance showed no correlation with
severity of reflux symptoms [severe symptoms 2376 X
(IQR 1251–3275 X) versus mild/moderate symptoms
2925 X (IQR 1083–3207 X), NS].
Proximal baseline impedance was significantly higher
when compared to distal baseline impedance [3116 X (IQR
2539–4071 X) versus 2445 X (IQR 1147–3277 X),
p\ 0.05]. Baseline impedance in the proximal segment
also showed a negative correlation with acid exposure time
(r -0.62, p = 0.001; Fig. 1B) and number of acid reflux
episodes (r -0.50, p = 0.01).
Proximal extension of reflux episodes occurred on
average in 44.8 % (SEM 4.8 %) of all reflux episodes. The
number of reflux episodes reaching the proximal esophagus
did not correlate with proximal baseline impedance
(r -0.18, NS).
Effects of laparoscopic antireflux surgery
LARS reduced acid exposure time from 8.5 %
(6.0–16.2 %) to 0.8 % (0.2–2.8 %), p\ 0.001, at 3-month
follow-up. All other reflux parameters, including the
number of proximal and non-acid GER episodes on 24-h
MII-pH monitoring, were also significantly reduced after
LARS (Table 2). LARS significantly increased baseline
impedance in both the distal and proximal impedance
segment (Fig. 2). Distal baseline impedance showed a
significant correlation with remaining postoperative acid
exposure time (r -0.67, p\ 0.001) (Fig. 3). Furthermore,
the change in distal baseline impedance after LARS cor-
related to the reduction in acid exposure time (r 0.48,
p = 0.02).
The median preoperative baseline impedance was
2445 X. After LARS, the baseline impedance value in
three patients was lower than this median preoperative
baseline impedance value (Fig. 3). In two of these three
patients, persisting pathologic acid exposure was found.
The third patient with lower postoperative baseline impe-
dance after the procedure had esophageal gastric meta-
plasia in the distal esophagus. Despite normalization of
acid exposure, low baseline impedance persisted only in
the most distal segment of the esophagus likely due to
increased conductivity of gastric epithelium.
Overall reflux symptoms significantly decreased after
LARS (p = 0.001). In 15 (65 %) patients, complete
remission of reflux symptoms was achieved and in an
additional 6 (26 %) patients symptom scores improved. In
two of the 23 (9 %) patients, reflux symptoms were unal-
tered; one of these patients showed a low baseline value
(536 X). Deterioration of reflux symptoms did not occur
(Table 3). Four patients with postoperative reflux com-
plaints and/or pathological reflux on 24-h pH monitoring
still required PPI therapy.
Similar to preoperative analysis, no association between
postoperative symptoms and baseline impedance could be
identified [no symptoms (n = 15) versus persistent symp-
toms (n = 8): 3917 X (IQR 3087–4490) versus 3706 X
(2983–4373), NS].
Determinants of the effect of LARS on baseline
impedance
A linear regression analysis was performed to explore
determinants of the effect of LARS on baseline impedance.
A BFig. 1 Correlation between
esophageal acid exposure time
(%) and A distal baseline
impedance (X) and B proximal
baseline impedance (X) in
GERD patients before LARS
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Age (b: -3.5 X; 95 % CI -114.6; 107.7, p = 0.95) and
type of fundoplication (b: -105.1 X; 95 % CI -1274.7;
1064.5, p = 0.95) did not affect the change in baseline
impedance after LARS. Also, the change in acid exposure
time (b: 50.7 X; 95 % CI -10.3; 111.7, p = 0.098) did not
reach statistical significance.
Discussion
In the present study, we investigated the effect of laparo-
scopic antireflux surgery (LARS) on baseline impedance as
a reflection of mucosal integrity in pediatric patients with
gastroesophageal reflux disease (GERD). Our main find-
ings were that LARS resulted in recovery of baseline
impedance, that reflux symptoms significantly decreased
after LARS, without an association with an increase in
baseline impedance and finally that no factors affecting the
effect of LARS on baseline impedance could be identified.
LARS aims to prevent reflux events from the stomach
thereby protecting the esophageal mucosa from potential
stressors in the refluxate. Previous studies have shown a
strong inverse correlation between baseline impedance and
acid exposure in pediatric GERD patients [9, 12, 22].
Accordingly, we hypothesized that successful elimination
of esophageal acid exposure by LARS would increase
baseline impedance. Our current study confirms this
hypothesis as it demonstrates a significant decrease in acid
exposure time and an increase in baseline impedance,
which likely reflects the recovery of the esophageal
mucosa. Furthermore, postoperative low distal baseline
Table 2 Reflux parameters on
MII-pH monitoring
Preoperative Postoperative p value
Acid exposure total (%, IQR) 8.5 (6.0–16.2) 0.8 (0.2–2.8) \0.001
Upright (%, IQR) 12.1 (4.8–19.2) 1.8 (0.5–5.9) 0.001
Supine (%, IQR) 7.1 (0.9–15.3) 0 (0–0) \0.001
Total GER (n, IQR) 92 (66–139) 14 (11–22) \0.001
Acid GER (n, IQR) 61 (34–94) 8 (1–13) \0.001
Non-acid GER (n, IQR) 23 (11–42) 5 (3–11) \0.001
Proximal reflux (n, IQR) 36 (14–87) 1 (0–3) \0.001
GER Gastroesophageal reflux, n number of reflux episodes, IQR interquartile range
Fig. 2 Baseline impedance in distal (z6) and proximal (z2)
esophageal segments before (red) and after (blue) LARS
Fig. 3 Correlation between acid exposure time (%) distal baseline
impedance (X) and after LARS. The horizontal dashed line indicates
preoperative median baseline impedance
Table 3 Symptom assessment
Preoperative (n, %) Postoperative (n, %) p value
Reflux symptoms
None 0 (0 %) 1 (65 %)
Mild 2 (9 %) 5 (22 %) 0.001
Moderate 6 (26 %) 2 (9 %)
Severe 15 (65 %) 1 (4 %)
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impedance was observed in patients with persistent
pathologic acid exposure time and in one patient with
gastric metaplasia. In the latter patient, this could be due to
the intrinsic higher conductive properties of columnar
epithelium when compared to esophageal squamous
epithelium [23].
Impaired mucosal integrity has been proposed as an
important mechanism in symptom generation, as it allows
acid reflux to permeate into the deeper layers of the mucosa
and activate sensory nerve endings [24]. Previous studies
have shown an association between esophageal mucosal
integrity and acid sensitivity using a standardized acid
perfusion test [25, 27]. Lower baseline impedance, as a
marker of impaired mucosal integrity, has also been shown
to correlate with clinical signs of GERD in the pediatric
population [12]. Related to these findings, recovery of
impaired mucosal integrity could hypothetically result in
improvement of reflux symptoms in GERD patients [6].
Laparoscopic antireflux surgery showed good clinical
outcome, but an association between GERD symptoms and
baseline impedance despite the use of validated question-
naires could not be identified. These results are in accor-
dance with previous studies attempting to identify a similar
association after PPI treatment in children or after endo-
scopic fundoplication in adults [12, 13]. Together, these
outcomes suggest that in addition to the mucosal integrity,
also content, proximal extent and volume of the refluxate,
as well as peripheral and central-mediated sensitivity,
affect GERD symptom perception [26, 27].
Baseline impedance may allow identification of patients
with impaired mucosal integrity after LARS, as it has been
associated with esophagitis and microscopic changes of the
mucosa [6, 9, 10, 28]. Post-procedural evaluation of GERD
is important as patients with persistent GERD may be at
risk of developing complications, such as esophagitis,
stenosis, Barrett’s epithelium and ultimately adenocarci-
noma of the esophagus [29]. GERD symptoms may not
always be evident, especially in younger children or chil-
dren with impaired neurodevelopment. Evaluation of
mucosal impedance during ambulatory 24-h MII-pH test-
ing may help to detect impaired mucosal integrity. MII-pH
analysis is, however, a time-consuming and the procedure
itself may be uncomfortable for pediatric patients.
Recently, other groups have reported on endoscopy guided
single-sensor catheters to measure mucosal impedance
during endoscopy [30, 31]. These catheters enable instant
evaluation of mucosal integrity during endoscopy instead
of the normal 24-h MII-pH monitoring. Unfortunately, in
children endoscopy is generally performed under general
anesthesia. Because of the impact and risks of the anes-
thesia and the invasive way endoscopy is performed, this
method in its current form seems unsuitable in pediatric
patients. Future developments may lead to alternative
methods that allow a similar instant evaluation of the
esophageal mucosa without using endoscopy [32].
In the proximal esophagus, an inverse correlation
between baseline impedance and (distal) acid exposure
time was seen, whereas no correlation with the number of
proximal reflux episodes was found. As the MII-pH
catheter used in this study only had a distal pH sensor, it is
not entirely clear whether proximal baseline impedance is
directly affected by acid reflux reaching the proximal
esophagus or by indirect mechanisms, activated by distal
acid exposure [33]. Previously, Farre et al. [33] showed
that distal acid perfusion resulted in changes in the mucosal
integrity of the non-exposed proximal esophagus, which is
suggestive for an indirect mucosal reaction spreading more
proximally than the site of mucosal injury. Further insights
in this possible mechanism of impaired mucosal integrity
in the proximal esophagus may be of clinical importance as
the proximal esophagus is often linked to symptom per-
ception [34–36].
Determinants, such as age, type of fundoplication or
change in acid exposure time, influencing the effect of LARS
on baseline impedance could not be identified. Infants and
young children previously were shown to have a lower
baseline impedance when compared to older (pediatric)
patients [37]. Age, however, did not influence the effect of
LARS on baseline impedance. Until now, studies on efficacy
of different types of fundoplication in both the adult and
pediatric population were not able to show differences in
reflux control [38, 39]. In this study type of fundoplication
also was not a significant determinant for the effect of LARS
on baseline impedance. The change in acid exposure time
after LARS showed a tendency to influence the effect of
LARS on baseline impedance and may have been a signifi-
cant determinant, if more patients had been included.
The main limitation in this current study is the number
of patients. A larger number of patients would have
allowed us to investigate determinants of interest in a linear
regression model with higher statistical power. Further-
more, in the current study endoscopy was not performed
per protocol. In 18 out of 25 (72 %) patients, endoscopy
was performed before LARS and in only a few of the
patients after the procedure. Data to correlate the changes
in baseline impedance with endoscopic and/or histological
mucosal findings are therefore not available. Pardon et al.
showed in adults that baseline impedance is closely cor-
related to evaluation of mucosal integrity by established
ex vivo methodology (Ussing Chamber technique) [10].
Together with previous findings from an experimental
model [6], these observations indicate that baseline impe-
dance is a reliable tool for the evaluation of mucosal
integrity in vivo.
In conclusion, LARS increased baseline impedance,
which is likely to reflect the recovery of mucosal integrity.
Surg Endosc (2017) 31:2910–2917 2915
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Although both baseline impedance and symptomatic reflux
control increased, these two parameters were not mutually
associated. Factors influencing the effect of LARS on
baseline impedance could not be identified.
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